Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs GGHCX overlap: 54% of top holdings shared

Bottom line

How much do FHLC and GGHCX overlap?

54% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 48.7% of FHLC's assets and 44.0% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 82), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCGGHCX
Weight overlap (top 25)54%
Shared holdings10
Weight in shared holdings48.7%44.0%
Total positions33782
Expense ratio0.084%1.07%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings FHLC and GGHCX have in common

Holding% of FHLC% of GGHCXOverlap
Eli Lilly & Co13.35%10.59%10.59%
Johnson & Johnson8.93%6.76%6.76%
AbbVie Inc6.42%4.03%4.03%
UnitedHealth Group Inc5.44%6.17%5.44%
Merck & Co Inc4.66%4.59%4.59%
Thermo Fisher Scientific Inc3.09%1.55%1.55%
Gilead Sciences Inc2.34%3.63%2.34%
CVS Health Corp1.92%2.52%1.92%
Vertex Pharmaceuticals Inc1.76%2.01%1.76%
Cardinal Health Inc0.78%2.10%0.78%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Amgen Inc — 3.00%
  2. Abbott Laboratories — 2.66%
  3. Pfizer Inc — 2.06%
  4. Bristol-Myers Squibb Co — 1.93%
  5. Intuitive Surgical Inc — 1.82%
  6. Danaher Corp — 1.80%
  7. Stryker Corp — 1.62%
  8. Medtronic PLC — 1.59%
  9. McKesson Corp — 1.52%
  10. Elevance Health Inc — 1.19%
  11. Regeneron Pharmaceuticals Inc — 1.15%
  12. Cigna Group/The — 1.06%
  13. Boston Scientific Corp — 1.00%
  14. HCA Healthcare Inc — 0.91%
  15. Cencora Inc — 0.83%

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. Welltower Inc. — 2.34%
  4. BrightSpring Health Services, Inc. — 2.20%
  5. Royalty Pharma PLC — 2.13%
  6. Guardant Health, Inc. — 2.04%
  7. Invesco Private Government Fund — 1.80%
  8. Axsome Therapeutics, Inc. — 1.58%
  9. Edwards Lifesciences Corp. — 1.56%
  10. Invesco Treasury Portfolio — 1.56%
  11. BridgeBio Pharma, Inc. — 1.43%
  12. Waters Corp. — 1.41%
  13. IQVIA Holdings Inc. — 1.32%
  14. U C B S.a. — 1.24%
  15. Ligand Pharmaceuticals Inc. — 1.18%

Asset mix

Asset typeFHLCGGHCX
Stocks99.7%97.5%
Cash & short-term funds0.2%8.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryFHLCGGHCX
US96.5%93.5%
NL0.1%3.4%
GB0.5%3.1%
CH0.1%2.7%
IE2.2%0.6%
BE—1.2%
DK—1.1%
IL—0.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do FHLC and GGHCX overlap?
About 54% by weight. 10 securities appear in both funds' top 25 holdings; they make up 48.7% of FHLC's assets and 44.0% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FHLC and GGHCX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Merck & Co Inc, AbbVie Inc.
Should I own both FHLC and GGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FHLC or GGHCX?
FHLC is broader, with 337 positions versus 82 for GGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.